This story was originally published on PolitiFact. Read it here. The federal government has changed its view of marijuana’s dependence and abuse risks, causing some confusion about what that means for ...
In recent years, GLP-1 receptor agonists have changed the way people discuss weight loss and diabetes treatment. The medications which doctors developed to treat Type 2 diabetes now serve as common ...
The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses.